This webinar will provide a real-world perspective on using a holistic approach to evaluate the effectiveness of a corporate compliance program. Attendees will also get an opportunity to assess the overall success of their organization’s corporate compliance program.
This webinar will examine the importance of evaluating the effectiveness of a corporate compliance program and provide insights on the methodologies for conducting such an evaluation. It will explore the enforcement environment faced by life sciences companies and the specific requirements imposed on the boards of directors by Office of Inspector General (OIG) Corporate Integrity Agreements to evaluate the effectiveness of corporate compliance programs.
Why Should You Attend:
Life sciences compliance professionals in organizations, who are charged with the responsibility of implementing a corporate compliance program, are likely to believe that they have put in place an effective program. But how do compliance professionals know if their program is really managing risk if they have not actually tested the program’s effectiveness?This webinar will examine the importance of evaluating the effectiveness of a corporate compliance program and provide insights on the methodologies for conducting such an evaluation. It will explore the enforcement environment faced by life sciences companies and the specific requirements imposed on the boards of directors by Office of Inspector General (OIG) Corporate Integrity Agreements to evaluate the effectiveness of corporate compliance programs.
Areas Covered in the Webinar:
- Corporate Integrity Agreement requirements
- Taking a holistic approach in evaluating effectiveness of corporate compliance programs
- Assessment of each element of your corporate compliance program
- Assessment of overall success of your corporate compliance program
- PhRMA Code external verification
Who Will Benefit:
This webinar will prove beneficial to personnel in life sciences companies/organizations receiving public payor reimbursement, and those working with pharmaceutical companies, medical devices companies and healthcare providers. Employees with key responsibilities who will benefit include:- Chief compliance officers and their staff
- Chief risk officers and their staff
- Enterprise risk management personnel
- General counsel/healthcare compliance legal counsel
- Members of compliance committees
- Senior management with responsibility to manage risk
- Board of directors
Course Provider
Brian A Dahl,
